Electrolyte and metabolic disturbances in ebola patients during a clinical Trial, Guinea, 2015

Emerging Infectious Diseases

Volumn 22, Issue 12, 2016, Pages 2120-2127

  van Griensven, Johan ^a   Bah, Elhadj Ibrahima ^b   Haba, Nyankoye ^c   Delamou, Alexandre ^d   Camara, Bienvenu Salim ^c   Olivier, Kadio Jean Jacques ^c   De Clerck, Hilde ^e   Nordenstedt, Helena ^e   Semple, Malcolm G ^f   Van Herp, Michel ^e   Buyze, Jozefien ^a   De Crop, Maaike ^a   Van Den Broucke, Steven ^a   Lynen, Lutgarde ^a   De Weggheleire, Anja ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Donka National Hospital   (Guinea)

^c National Blood Transfusion Center   (Guinea)

^d National Center for Training and Research in Rural Health of Maferinyah   (Guinea)

^e MÉDECINS SANS FRONTIÈRES   (Belgium)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CARBON DIOXIDE; CHLORIDE; CREATININE; HEMOGLOBIN; NEUTRALIZING ANTIBODY; ORAL REHYDRATION SOLUTION; SODIUM; BIOLOGICAL MARKER; ELECTROLYTE;

ADULT; ANEMIA; ANION GAP; ARTICLE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; EBOLA HEMORRHAGIC FEVER; ELECTROLYTE DISTURBANCE; FEMALE; HISTOGRAM; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; MORTALITY RISK; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTOR; UREA NITROGEN BLOOD LEVEL; YOUNG ADULT; BLOOD; ENERGY METABOLISM; GUINEA; METABOLISM; MORTALITY; PLASMA; POINT OF CARE SYSTEM; PREGNANCY; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX;

ADULT; BIOMARKERS; CLINICAL TRIALS AS TOPIC; ELECTROLYTES; ENERGY METABOLISM; FEMALE; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; PLASMA; POINT-OF-CARE SYSTEMS; PREGNANCY; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84995969151     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2212.161136     Document Type: Article

References (34)

1. World Health Organization. Ebola situation report—30 March 2016 [cited 2016 Jun 1]. http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016
2. van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med. 2016;374:33–42. http://dx.doi.org/10.1056/NEJMoa1511812
3. Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, et al. Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial. PLoS Med. 2016;13:e1001997. http://dx.doi.org/10.1371/journal.pmed.1001997
4. Sissoko D, Laouenan C, Folkesson E, M’Lebing AB, Beavogui AH, Baize S, et al. Experimental treatment with favipiravir for Ebola Virus Disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967. http://dx.doi.org/10.1371/journal.pmed.1001967
5. Fletcher TE, Fowler RA, Beeching NJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med. 2014;40:1936–9. http://dx.doi.org/10.1007/s00134-014-3515-1
6. Fowler RA, Fletcher T, Fischer WA II, Lamontagne F, Jacob S, Brett-Major D, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med. 2014;190:733–7.
7. Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA II, Fowler RA. Doing today’s work superbly well—treating Ebola with current tools. N Engl J Med. 2014;371:1565–6. http://dx.doi.org/10.1056/NEJMp1411310
8. Wong KK, Perdue CL, Malia J, Kenney JL, Peng S, Gwathney JK, et al. Supportive care of the first 2 Ebola virus disease patients at the Monrovia Medical Unit. Clin Infect Dis. 2015;61:e47–51. http://dx.doi.org/10.1093/cid/civ420
9. West TE, von Saint André-von Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc. 2014;11:1341–50. http://dx.doi.org/10.1513/AnnalsATS.201410-481PS
10. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371:2054–7. http://dx.doi.org/10.1056/NEJMp1413084
11. Hunt L, Lee JS. Empiric intravenous fluid and electrolyte therapy in patients with Ebola virus disease. Trop Doct. 2016;46:148–50. http://dx.doi.org/10.1177/0049475516644883
12. Palich R, Gala JL, Petitjean F, Shepherd S, Peyrouset O, Abdoul BM, et al. A 6-year-old child with severe Ebola virus disease: laboratory-guided clinical care in an Ebola treatment center in Guinea. PLoS Negl Trop Dis. 2016;10:e0004393. http://dx.doi.org/10.1371/journal.pntd.0004393
13. Clay KA, Johnston AM, Moore A, O’Shea MK. Targeted electrolyte replacement in patients with Ebola virus disease. Clin Infect Dis. 2015;61:1030–1. http://dx.doi.org/10.1093/cid/civ435
14. Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374:636–46. http://dx.doi.org/10.1056/NEJMoa1504874
15. Kok J, Sintchenko V, Dwyer DE, Chen SC. Laboratory preparedness for Ebolavirus disease [editorial]. Pathology. 2015;47:397–9. http://dx.doi.org/10.1097/PAT.0000000000000290
16. Hunt L, Knott V. Serious and common sequelae after Ebola virus infection. Lancet Infect Dis. 2016;16:270–1. http://dx.doi.org/10.1016/S1473-3099(15)00546-0
17. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007;196(Suppl 2):S364–71. http://dx.doi.org/10.1086/520613
18. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371:2402–9. http://dx.doi.org/10.1056/NEJMoa1409838
19. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014;371:2394–401. http://dx.doi.org/10.1056/NEJMoa1411677
20. Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10:e1001381. http://dx.doi.org/10.1371/journal.pmed.1001381
21. Sterck A. Filovirus haemorrhagic fever guideline [cited 2016 Jun 1]. http://www.medbox.org/ebola-guidelines/filovirus-haemorrhagic-fever-guideline/preview
22. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: The Organization; 2011.
23. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372:40–7. http://dx.doi.org/10.1056/NEJMoa1411249
24. Faye O, Andronico A, Faye O, Salje H, Boëlle PY, Magassouba N, et al. Use of viremia to evaluate the baseline case fatality ratio of Ebola virus disease and inform treatment studies: a retrospective cohort study. PLoS Med. 2015;12:e1001908. http://dx.doi.org/10.1371/journal.pmed.1001908
25. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87. http://dx.doi.org/10.1002/(SICI)1097- 0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
26. Hunt L, Gupta-Wright A, Simms V, Tamba F, Knott V, Tamba K, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015;15:1292–9. http://dx.doi.org/10.1016/S1473-3099(15)00144-9
27. Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008;4:CD006163. http://dx.doi.org/10.1002/14651858.CD006163.pub2
28. Collage RD, Howell GM, Zhang X, Stripay JL, Lee JS, Angus DC, et al. Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium/calmodulin-dependent protein kinase kinase signaling. Crit Care Med. 2013;41:e352–60. http://dx.doi.org/10.1097/CCM.0b013e31828cf436
29. van Griensven J, Phirum L, Thai S, Buyze J, Lynen L. A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia. J Acquir Immune Defic Syndr. 2014;65:e150–2. http://dx.doi.org/10.1097/QAI.0000000000000022
30. van Griensven J, Phan V, Thai S, Koole O, Lynen L. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. PLoS One. 2014;9:e87879. http://dx.doi.org/10.1371/journal.pone.0087879
31. Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997;155:1618–23. http://dx.doi.org/10.1164/ajrccm.155.5.9154866
32. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–17. http://dx.doi.org/10.1056/NEJM199902113400601
33. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371:2092–100. http://dx.doi.org/10.1056/NEJMoa1411680
34. Faubel S, Franch H, Vijayan A, Barron MA, Heung M, Liu KD, et al. Preparing for renal replacement therapy in patients with the Ebola virus disease. Blood Purif. 2014;38:276–85. http://dx.doi.org/10.1159/000371530